Reykjavik, Iceland

Jakob Lindal Kristinsson

This inventor holds 1 USPTO granted patent. Top assignee: Lyfjathroun Hf.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jakob Lindal Kristinsson. Retrieved from https://idiyas.com/inventor/jakob-lindal-kristinsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jakob Lindal Kristinsson

Introduction

Jakob Lindal Kristinsson is a notable inventor based in Reykjavik, Iceland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug absorption. His work is characterized by a focus on improving therapeutic delivery methods.

Latest Patents

Jakob holds 1 patent for an invention titled "Absorption Promoting Agent." This patent relates to pharmaceutical compositions that include polyoxyethylene glycol and fatty acid mono- and diglyceride esters as absorption promoting agents. These compositions are designed for mucosal administration, such as intranasal delivery, making them particularly valuable in medical applications.

Career Highlights

Throughout his career, Jakob has demonstrated a commitment to advancing pharmaceutical technology. His innovative approach to drug formulation has the potential to improve patient outcomes by enhancing the efficacy of therapeutic agents.

Collaborations

Jakob has collaborated with notable colleagues, including David Rurik Olafsson and Oddur Ingolfsson. These partnerships have contributed to the development of his innovative pharmaceutical compositions.

Conclusion

Jakob Lindal Kristinsson's work exemplifies the intersection of innovation and healthcare. His contributions to pharmaceutical compositions are paving the way for more effective drug delivery methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…